lomefloxacin has been researched along with isoniazid in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (23.08) | 18.2507 |
| 2000's | 7 (53.85) | 29.6817 |
| 2010's | 2 (15.38) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| China, A; Dinakaran, M; Nagaraja, V; Senthilkumar, P; Sriram, D; Yogeeswari, P | 4 |
| Banerjee, D; China, A; Devakaram, RV; Dinakaran, M; Nagaraja, V; Senthilkumar, P; Sriram, D; Yogeeswari, P | 1 |
| Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bai, L; Deng, JL; Gao, F; Lv, ZS; Wang, Y; Xu, Z; Zhang, F; Zhao, SJ | 1 |
| Makarova, OV; Mikhaĭlova, LP; Mozhokina, GN; Sokolova, GB | 1 |
| Koriakin, VA; Kunichan, AD; Lazareva, IaV; Sokolova, GB | 1 |
| Martynova, LP; Mishin, VIu; Vasil'eva, IA | 1 |
| Dolgushin, MV | 1 |
2 review(s) available for lomefloxacin and isoniazid
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Fluoroquinolone-isatin hybrids and their biological activities.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antineoplastic Agents; Antitubercular Agents; Antiviral Agents; Fluoroquinolones; Humans; Isatin; Structure-Activity Relationship | 2019 |
1 trial(s) available for lomefloxacin and isoniazid
| Article | Year |
|---|---|
[Lomefloxacin in complex treatment of acute progressive form of pulmonary tuberculosis].
Topics: Acute Disease; Adolescent; Adult; Animals; Anti-Infective Agents; Antibiotics, Antitubercular; Antitubercular Agents; Colony Count, Microbial; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Ethambutol; Fluoroquinolones; Humans; Isoniazid; Mice; Middle Aged; Pyrazinamide; Quinolones; Streptomycin; Treatment Outcome; Tuberculosis, Pulmonary | 1998 |
10 other study(ies) available for lomefloxacin and isoniazid
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Antimycobacterial activities of novel 1-(cyclopropyl/tert-butyl/4-fluorophenyl)-1,4-dihydro- 6-nitro-4-oxo-7-(substituted secondary amino)-1,8-naphthyridine-3-carboxylic acid.
Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Drug Resistance, Multiple, Bacterial; Female; Light; Mice; Microbial Sensitivity Tests; Mycobacterium smegmatis; Mycobacterium tuberculosis; Naphthyridines; Structure-Activity Relationship; Topoisomerase II Inhibitors; Vero Cells | 2007 |
Novel ofloxacin derivatives: synthesis, antimycobacterial and toxicological evaluation.
Topics: Animals; Antitubercular Agents; Combinatorial Chemistry Techniques; DNA Gyrase; Enzyme Inhibitors; Fluoroquinolones; Gatifloxacin; Lung; Mice; Molecular Structure; Mycobacterium tuberculosis; Ofloxacin; Spleen; Structure-Activity Relationship; Topoisomerase II Inhibitors | 2008 |
Synthesis and antimycobacterial evaluation of newer 1-cyclopropyl-1,4-dihydro-6-fluoro-7-(substituted secondary amino)-8-methoxy-5-(sub)-4-oxoquinoline-3-carboxylic acids.
Topics: Amination; Animals; Anti-Bacterial Agents; Cell Survival; Chlorocebus aethiops; Cyclopropanes; DNA Gyrase; Fluorine Compounds; Hydroxyquinolines; Molecular Structure; Mycobacterium; Photosensitizing Agents; Structure-Activity Relationship; Topoisomerase II Inhibitors; Vero Cells | 2008 |
Antimycobacterial activities of novel 2-(sub)-3-fluoro/nitro-5,12-dihydro-5-oxobenzothiazolo[3,2-a]quinoline-6-carboxylic acid.
Topics: Animals; Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Lung; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium smegmatis; Mycobacterium tuberculosis; Quinolines; Spleen; Structure-Activity Relationship | 2008 |
Synthesis and antimycobacterial activities of novel 6-nitroquinolone-3-carboxylic acids.
Topics: Animals; Anti-Bacterial Agents; Carboxylic Acids; Chlorocebus aethiops; DNA Gyrase; Lung Diseases; Mice; Microbial Sensitivity Tests; Mycobacterium smegmatis; Mycobacterium tuberculosis; Quinolines; Splenic Diseases; Structure-Activity Relationship; Vero Cells | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
[Antitubercular activity of lomefloxacin in an experiment].
Topics: Animals; Anti-Infective Agents; Antitubercular Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Fluoroquinolones; Isoniazid; Lung; Mice; Mycobacterium tuberculosis; Quinolones; Reference Values; Spleen; Survival Rate; Tuberculosis | 1996 |
[Efficiency of lomefloxacine in combined treatment of patients with multiresistant pulmonary tuberculosis complicated with nonspecific bronchopulmonary infection].
Topics: Adult; Anti-Infective Agents; Antitubercular Agents; Fluoroquinolones; Humans; Isoniazid; Middle Aged; Quinolones; Respiratory Tract Infections; Rifampin; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1999 |
Cytochemical Evaluation of the Toxic Effects of Combined Antituberculosis Substances on Metabolic State of Blood Lymphocytes.
Topics: Acid Phosphatase; Administration, Oral; Animals; Animals, Outbred Strains; Antitubercular Agents; Drug Combinations; Esterases; Ethambutol; Fluoroquinolones; Gene Expression; Glycerolphosphate Dehydrogenase; Isoniazid; L-Lactate Dehydrogenase; Lymphocytes; Male; Primary Cell Culture; Prothionamide; Pyrazinamide; Rats; Rifampin; Succinate Dehydrogenase | 2020 |